This inventor holds 11 USPTO granted patents. Top assignees: Boehringer Ingelheim Gmbh, Boehringer Ingelheim Gesellschaft MIT Beschrankter Haftung, Dr. Karl Thomae Gesellschaft MIT Beschrankter Haftung. Active years: 1976-1983.
Location History:
- Biberach an der Riss, DE (1976 - 1978)
- Biberach, DE (1977 - 1983)
Company Filing History:
9 out of 306 
1 out of 1 
1 out of 21 Years Active: 1976-1983
Title: Eberhard Kutter: Innovator in Pharmaceutical Sciences
Introduction
Eberhard Kutter is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of coronary heart diseases. With a total of 11 patents, Kutter's work has had a profound impact on medical research and drug development.
Latest Patents
Kutter's latest patents include a method of treating coronary heart disease with imidazo(4,5-B)pyridines. This invention involves pharmaceutical compositions containing a specific compound formula, where R1 is an alkoxy group of 1 to 4 carbon atoms, and R2 is an alkyl sulfinyl group. This method aims to provide effective treatment for coronary heart diseases or spasms. Another significant patent is related to 8-phenyl-purines and their pharmaceutical compositions. This invention focuses on 8-phenyl-purines of a general formula, where R1 can be a hydrogen or halogen atom, among other variations.
Career Highlights
Throughout his career, Eberhard Kutter has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim GmbH and Boehringer Ingelheim Gesellschaft mit beschränkter Haftung. His work in these organizations has contributed to advancements in drug formulations and therapeutic methods.
Collaborations
Kutter has collaborated with esteemed colleagues such as Joachim Heider and Volkhard Austel. These partnerships have fostered innovation and have been instrumental in the development of new pharmaceutical solutions.
Conclusion
Eberhard Kutter's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the treatment of coronary heart diseases, showcasing the importance of innovation in healthcare.